Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

ESMO Preceptorship on Gastroenteropancreatic Neuroendocrine Neoplasms 2019: Prague

ESMO Preceptorship Gastroenteropancreatic Neuroendocrine Neoplasms Cancer Prague 2019
Start date
12 Apr 2019
End date
13 Apr 2019
Location
Prague, Czech Republic

Learning objectives

  • Familiarise with the epidemiology, classification and prognostication of Gastroenteropancreatic (GEP) Neuroendocrine Neoplasms (NEN) patients
  • Introduce principles of diagnostic and therapeutic strategy and the role of a multidisciplinary team
  • Integrate different therapies in patients with advanced disease
  • Familiarise with the genetic aberrations and their evolving role in diagnosis and treatment
  • Update of new developments, clinical trials and unmet needs

Download the programme

Accreditation

The programme of this event will be accredited with 9 ESMO-MORA category 1 points. Recertification is necessary for medical oncologists to remain professionally certified by ESMO. Recertification guarantees that a certified medical oncologist has continued to update her/his knowledge and continues to possess the necessary skills and standards for the practice of medical oncology. For further details, please refer to  ESMO-MORA Recertification Process & Requirements.

Co-Chairs

  • Nicola Fazio, Italy
  • Gregory Kaltsas, Greece

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.